v3.19.3

Note 6 - Accrued Liabilities | 9 Months Ended
--- | ---
Sep. 30, 2019
Notes to Financial Statements |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | Note 6. Accrued Liabilities Accrued liabilities consist of the following (in thousands):
|  | September 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
Payroll and related expenses |  | $ | 640 |  |  | $ | 241 |
Accrued term loan final payment |  |  | 608 |  |  |  | 421 |
Accrued clinical trial expense |  |  | 26 |  |  |  | - |
Professional fees and other costs |  |  | 899 |  |  |  | 195 |
Total accrued liabilities |  | $ | 2,173 |  |  | $ | 857 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration